Pharmaceutical Technology

DECEMBER 14, 2022

GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The discovery alliance, with a preliminary research period of four years, will aid GSK in progressing up to eight programmes and Wave to develop up to three programmes.

Communication 64

Communication FDA 64

Pharmaceutical Technology

JANUARY 11, 2023

AbbVie has collaborated with Anima Biotech for the discovery and development of mRNA biology modulators against three oncology and immunology targets. The power of our mRNA Lightning platform is validated by our multiple partnerships and a growing internal pipeline.”. Free Whitepaper.

Communication 59

Communication 59

Pharmaceutical Technology

MAY 31, 2023

The funding will also be used to work on Anocca’s cell therapy discovery and manufacturing process. The Södertälje, Sweden-headquartered company’s preclinical pipeline is designed to focus on a range of targets for its T-cell receptor candidates. Topic sponsors are not involved in the creation of editorial content.

Vaccines 52

Vaccines 52

Roots Analysis

AUGUST 14, 2023

The contemporary TCR therapies market is characterized by a healthy and growing pipeline of more than 190 candidate therapies. Moreover, the ongoing research activity in this field has led to the discovery of several novel molecular targets, further strengthening the research pipelines of companies engaged in this market.

52

52

pharmaphorum

MARCH 19, 2021

Gain Therapeutics has priced its initial public offering, raising more than $40 million for its computational drug discovery platform and pipeline of drugs for diseases associated with protein misfolding. . The shares began trading on the Nasdaq yesterday under the symbol ‘GANX’, closing at $11.20

92

92

IDStewardship

JUNE 5, 2023

To shed light on this important topic, we had the privilege of interviewing an esteemed expert [ChatGPT by OpenAI] in the field of antimicrobial stewardship. Drug discovery and development: AI can accelerate the process of discovering and developing new antimicrobial drugs.

Vaccines 234

Vaccines Hospitals Patient Care 234

Pharmaceutical Technology

JANUARY 4, 2023

At MaxCyte, we are passionate about driving the discovery, development and manufacturing of next-generation, cell-based medicines to tackle complex diseases and cancer. “We We are excited to support Catamaran with the advancement of their pipeline of differentiated CAR-NK cell therapies into and through the clinic.”. Free Whitepaper.

Communication 52

Communication 52

pharmaphorum

JANUARY 19, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022.

Hospitals 83

Hospitals Vaccines 83

ISPE

SEPTEMBER 28, 2023

California’s world-class education system has created an unparalleled talent pipeline – more than 3.7 Moreover, the pressing concerns of climate change resonate across diverse scientific domains, and it's conceivable that the subsequent monumental discovery might emerge from within a California-based life sciences entity.

Hospitals 98

Hospitals Documentation Pharmaceutical Companies Pharmaceutical Companies 98

Roots Analysis

AUGUST 29, 2023

However, there are several complexities associated with the discovery, development and manufacturing of such products. Other key concerns shared by contemporary innovators include limited availability of expertise, high rate of attrition of pipeline drugs / therapies and prolonged development timelines.

40

40

pharmaphorum

APRIL 15, 2021

The pharma organisation prides itself on having an open, collaborative, “science first” approach to help ensure breakthrough discoveries have the very best chance of long-term success in bringing new treatment options to patients worldwide. Collaboration accelerates progress for patients.

Labelling 62

Labelling Communication FDA Pharmaceutical Companies 62

pharmaphorum

DECEMBER 14, 2022

Healthcare transformation has been a widely discussed topic for years, with many arguing for a more streamlined and tech- and data-driven approach to the industry that affects all people. He is on the board of Genialis, an AI drug discovery company, and a venture partner at First Star Ventures, a Boston-based deep tech fund.

105

105

pharmaphorum

JANUARY 23, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. A lot of drug discovery, though, is for those people who don’t want to change their behaviour.”

90

90

Viseven

JULY 11, 2023

After using Salesforce Nonprofit Cloud to track donor activity, the organizations added to the cloud CRM analytics and Einstein Discovery AI (now Einstein GPT) to get a 360-degree view of the donor pipeline and actionable insights for its optimization.

Health and Personal Care Stores 40

Health and Personal Care Stores Scheduling Appointments Communication Documentation 40

PharmaShots

FEBRUARY 22, 2023

Registration link: [link] In this edition, the latest technological interventions in pharma R&D and manufacturing will be explored, such as biomarker discovery, cell and gene therapies, biologics, and nanomedicines.

Patient Care 58

Patient Care 58

Pharmaceutical Technology

MAY 11, 2023

The collaboration will see the companies using each others’ proprietary technology platforms for the discovery of peptide-radioisotope conjugates as potential treatments. Topic sponsors are not involved in the creation of editorial content. Early R&D projects coverage on Pharmaceutical Technology is supported by Mimotopes.

Immunization 52

Immunization Labelling Communication 52

Pharmaceutical Technology

JUNE 15, 2023

The collaboration will use Confo Therapeutics’ suite of ConfoBody-enabled antibody discovery technologies on two undisclosed GPCR targets. These GPCRs will be leveraged as antigens for the discovery and development of antibodies. Topic sponsors are not involved in the creation of editorial content.

Communication 52

Communication 52

Pharmaceutical Technology

MAY 16, 2023

The companies entered into a ten-year partnership to co-develop and co-commercialise current and future cancer therapeutic candidates in Arcus’s pipeline. Topic sponsors are not involved in the creation of editorial content. Gilead will have an option to license each programme at two separate, pre-specified time points.

Communication 52

Communication 52

Pharmaceutical Technology

JUNE 18, 2023

We look forward to working together to accelerate target discovery and preclinical research in this area of high unmet need.” Topic sponsors are not involved in the creation of editorial content. Early R&D projects coverage on Pharmaceutical Technology is supported by Mimotopes.

Packaging 52

Packaging Communication 52

Pharmaceutical Technology

MARCH 8, 2023

Molecular science and technology firm Caris Life Sciences and Incyte have entered a strategic research collaboration to advance the latter’s oncology pipeline. Topic sponsors are not involved in the creation of editorial content. Incyte will have the option to expand to a total of four programmes.

Communication 52

Communication 52